Skip to main content Skip to navigation

Building a Sustainable UK Diagnostic Sector II: the Regional Dimension - West Midlands Leading the Way?

Thursday 15 December, 2022 - 09:30am - 3.30pm - In-person event

Location: University of Warwick Oculus Building

About the event:

Our first meeting held in September 2021 considered how we can best exploit the commercial, scientific and health opportunities in diagnostics driven by the new knowledge, investment and innovation demonstrated by the UK diagnostics sector in response to Covid 19. This follow-on conference will consider the regional opportunities afforded by these developments and consider how we can best leverage our cross-sector strengths to build a world-leading diagnostics enterprise in the West Midlands.

As before, this event will bring together key stakeholders from across the NHS, academia, industry and regulatory bodies to explore how we can enhance cross-sector collaboration to turbo-charge local growth by building the infrastructure necessary for the development and implementation of innovative diagnostics. With a focus on our distinctive expertise in diagnostics, data and devices, we will consider how best to exploit these assets to create a sustainable and internationally-recognised activity in the West Midlands.

Speakers include:
  • Karen Taylor, Director, Deloitte Centre for Health Solutions
  • Neil Anderson, Consultant Clinical Biochemist UHCW, Director UHCW Institute of Precision Diagnostics
  • Dr Justin Varney, Director of Public Health - Birmingham City Council
  • Alex Richter, Director of the Clinical Immunology Service, University of Birmingham. Consultant Clinical Immunologist University Hospitals Birmingham
  • David Snead, Pathology Consultant UHCW
  • Mark Elliott - Associate Professor, Warwick Manufacturing Group
  • Nick Barnes, Principal Founder, Director and CEO, Celentyx Ltd
  • Yiannis Maos, Founder & CEO - Birmingham Tech & Paddie Murphy, West Midlands Health Technology Cluster
  • Richard Sullivan, Global Oncology Group - Institute of Cancer Policy / Conflict & Health Research Group
  • Dimitris Grammatopoulos, Professor of Molecular Medicine, Warwick Medical School, Consultant Clinical Biochemist UHCW
  • Collaborators: Warwick Health GRP, West Midlands Health Technology Cluster

Register here

If you have any queries about the event, please contact HealthGRP at warwick dot ac dot uk

Find out more about our Industry and Stakeholder Forum